Diabetes Therapy
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

3.179

12.5%

Journal Impact IF Trend

Related Journals

Popular Journals

Diabetes Therapy

The 2019-2020 Journal Impact IF of Diabetes Therapy is 3.179, which is just updated in 2020.

Diabetes Therapy Impact Factor
Highest IF
3.326
Highest Journal Impact IF

The highest Journal Impact IF of Diabetes Therapy is 3.326.

Lowest IF
0.222
Lowest Journal Impact IF

The lowest Journal Impact IF of Diabetes Therapy is 0.222.

Total Growth Rate
1332.0%
IF Total Growth Rate

The total growth rate of Diabetes Therapy IF is 1332.0%.

Annual Growth Rate
148.0%
IF Annual Growth Rate

The annual growth rate of Diabetes Therapy IF is 148.0%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Endocrinology, Diabetes and Metabolism Q2 93/217

Endocrinology, Diabetes and Metabolism 57%

Internal Medicine Q2 42/128

Internal Medicine 67%

Journal Impact IF Ranking

· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Diabetes Therapy is Q2. Diabetes Therapy has been ranked #93 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Diabetes Therapy is around 57% in the field of Endocrinology, Diabetes and Metabolism.
· In the Internal Medicine research field, the Quartile of Diabetes Therapy is Q2. Diabetes Therapy has been ranked #42 over 128 related journals in the Internal Medicine research category. The ranking percentile of Diabetes Therapy is around 67% in the field of Internal Medicine.

Diabetes Therapy Impact Factor 2020-2021 Prediction

Diabetes Therapy Impact Factor Predition System

Diabetes Therapy Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
984
Total Citations
8807

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 3.179
2018-2019 2.827
2017-2018 2.224
2016-2017 2.368
2015-2016 2.419
2014-2015 3.326
2013-2014 3.069
2012-2013 1.25
2011-2012 0.222
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Diabetes Therapy is 3.179
· The 2018-2019 Journal Impact IF of Diabetes Therapy is 2.827
· The 2017-2018 Journal Impact IF of Diabetes Therapy is 2.224
· The 2016-2017 Journal Impact IF of Diabetes Therapy is 2.368
· The 2015-2016 Journal Impact IF of Diabetes Therapy is 2.419
· The 2014-2015 Journal Impact IF of Diabetes Therapy is 3.326
· The 2013-2014 Journal Impact IF of Diabetes Therapy is 3.069
· The 2012-2013 Journal Impact IF of Diabetes Therapy is 1.25
· The 2011-2012 Journal Impact IF of Diabetes Therapy is 0.222

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
2010 9 1
2011 15 9
2012 14 73
2013 35 183
2014 43 379
2015 51 510
2016 62 649
2017 114 954
2018 193 1205
2019 180 1939
2020 265 2737
2021 3 168
Publications Cites Dataset

· The Diabetes Therapy has published 9 reports and received 1 citations in 2010.
· The Diabetes Therapy has published 15 reports and received 9 citations in 2011.
· The Diabetes Therapy has published 14 reports and received 73 citations in 2012.
· The Diabetes Therapy has published 35 reports and received 183 citations in 2013.
· The Diabetes Therapy has published 43 reports and received 379 citations in 2014.
· The Diabetes Therapy has published 51 reports and received 510 citations in 2015.
· The Diabetes Therapy has published 62 reports and received 649 citations in 2016.
· The Diabetes Therapy has published 114 reports and received 954 citations in 2017.
· The Diabetes Therapy has published 193 reports and received 1205 citations in 2018.
· The Diabetes Therapy has published 180 reports and received 1939 citations in 2019.
· The Diabetes Therapy has published 265 reports and received 2737 citations in 2020.
· The Diabetes Therapy has published 3 reports and received 168 citations in 2021.
· The total publications of Diabetes Therapy is 984.
· The total citations of Diabetes Therapy is 8807.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Diabetes Therapy | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Diabetes Therapy Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Diabetes Therapy during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Diabetes Therapy.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Diabetes Therapy
Journal Profile

About

Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research. None

Highly Cited Keywords

ISSN
1869-6953
ISSN

The ISSN of Diabetes Therapy is 1869-6953 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1869-6961
ISSN (Online)

The ISSN (Online) of Diabetes Therapy is 1869-6961 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Springer Publishing Company
Publisher

Diabetes Therapy is published by Springer Publishing Company .

Publication Frequency
Other
Publication Frequency

Diabetes Therapy publishes reports Other .

Coverage
2010 - Present
Coverage

The Publication History of Diabetes Therapy covers 2010 - Present .

Open Access
YES
Open Access

Diabetes Therapy is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Much scientific and medical research is paid for with public funds. Open Access allows taxpayers to see the results of their investment.

Publication Fee
Publication Fee

Diabetes Therapy is an Open Access (OA) Journal. Open Access stands for unrestricted access and unrestricted reuse. With Open Access, researchers can read and build on the findings of others without restriction. Open Access allows taxpayers to see the results of their investment. Please share or review the publication fee with the community.

Language
English
Language

The language of Diabetes Therapy is English .

Country/Region
United States
Country/Region

The publisher of Diabetes Therapy is Springer Publishing Company , which locates in United States .

Selected Articles

Full Title Authors
Full Title Authors
Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years Qian Li · Rahul Ganguly · Michael L. Ganz · Cory Gamble · Tam Dang-Tan · Tam Dang-Tan
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study Paul H. Lee · Yunjuan Gu · Man Yi Yeung · Carol H.Y. Fong · Yu-Cho Woo · Ws Chow · Kathryn C.B. Tan · Karen Siu Ling Lam · Karen Siu Ling Lam
SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice Gagan Priya · Sanjay Kalra · Sanjay Kalra
Individuals with Type 1 and Type 2 Diabetes Mellitus Trade Increased Hyperglycemia for Decreased Hypoglycemia When Glycemic Variability is not Improved Leonardo Spatola · Silvia Finazzi · Claudio Angelini · Marco Dauriz · Salvatore Badalamenti · Salvatore Badalamenti
iGlarLixi Reduces Glycated Hemoglobin to a Greater Extent Than Basal Insulin Regardless of Levels at Screening: Post Hoc Analysis of LixiLan-L Sujit R. Jangam · Gary A. Hayter · Timothy C. Dunn · Timothy C. Dunn
In Vitro Inhibitory Activity of Acca sellowiana Fruit Extract on End Products of Advanced Glycation Elisabeth Niemoeller · Elisabeth Souhami · Yujun Wu · Klaus Jensen · Klaus Jensen
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study Alethia Muñiz · Abraham H. Garcia · Rosa Pérez · Efren V. García · Daphne Gonzalez · Daphne Gonzalez
Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima–Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study George Grunberger · Sarah Camp · Jeremy Johnson · Susan Huyck · Steven G. Terra · James P. Mancuso · Zhi Wei Jiang · Gregory T. Golm · Samuel S. Engel · Brett Lauring · Brett Lauring
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus Keiji Yoshioka · Keiji Yoshioka
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study Marc Evans · Plamen Kozlovski · Päivi M. Paldánius · James E. Foley · Vaishali Bhosekar · Carmen Serban · Angelo Avogaro · Angelo Avogaro
Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol Alessandro Ciresi · Enrica Vigneri · Stefano Radellini · Felicia Pantò · Carla Giordano · Carla Giordano
A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes Gary Deed · Gary Kilov · Trisha Dunning · Richard Cutfield · Jane Overland · Jane Overland · Ted Wu · Ted Wu
Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial Ameer Khowaja · Jamil B. Alkhaddo · Jamil B. Alkhaddo · Zaighum Rana · Lisa H. Fish · Lisa H. Fish
Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire Selcuk Dagdelen · Oguzhan Deyneli · Nermin Olgun · Zeynep Osar Siva · Mehmet Sargin · Sükrü Hatun · Mustafa Kulaksizoglu · Ahmet Kaya · Cansu Aslan Gürlek · Laurence J. Hirsch · Kenneth Strauss · Kenneth Strauss
Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial Wei Li · Fan Ping · Lingling Xu · Huabing Zhang · Yaxiu Dong · Hongmei Li · Qi Sun · Yuxiu Li · Yuxiu Li
Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries Goran Petrovski · Dashamir Gjergji · Aleksandra Grbic · Blazenko Vukovic · Mitja Krajnc · Natasa Grulovic · Natasa Grulovic
Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials Annaswamy Raji · Jianmin Long · Raymond Lam · Edward A. O’Neill · Samuel S. Engel · Samuel S. Engel
Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire Selcuk Dagdelen · Oguzhan Deyneli · Nermin Olgun · Zeynep Osar Siva · Mehmet Sargin · Sükrü Hatun · Mustafa Kulaksizoglu · Ahmet Kaya · Cansu Aslan Gürlek · Laurence J. Hirsch · Kenneth Strauss · Kenneth Strauss
Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial Mats De Jaeger · Lisa Goudman · Peter Van Schuerbeek · Johan De Mey · Bart Keymeulen · Raf Brouns · Maarten Moens · Maarten Moens
A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin? Mickael Basson · Dionysios Ntais · Ruba Ayyub · Donna Wright · Julia Lowin · Florence Chartier · S Roze · Kirsi Norrbacka · Kirsi Norrbacka
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France Irini P. Chatziralli · Irini P. Chatziralli
The Role of Glycemic Control and Variability in Diabetic Retinopathy Weina Gao · Lingling Pu · Jingyu Wei · Zhanxin Yao · Yawen Wang · Tala Shi · Liting Zhao · Changya Jiao · Changjiang Guo · Changjiang Guo
Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis Noriyuki Iwamoto · Akiko Matsui · Hirotaka Kazama · Tomonori Oura · Tomonori Oura
Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes K. V. S. Hari Kumar · Rahul Sharma · Manish Manrai · Aditya Sood · Aditya Sood
Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections Tejasav Sehrawat · Anuraag Jindal · Paaras Kohli · Amit Thour · Jasbinder Kaur · Atul Sachdev · Yashdeep Gupta · Yashdeep Gupta
A class comparison of medication persistence in people with type 2 diabetes: a retrospective observational study Will Fry · Sean McCafferty · Catherine Gooday · Catherine Gooday · Ian Nunney · Ketan Dhatariya · Ketan Dhatariya · Ketan Dhatariya
HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study Andrew McGovern · William Hinton · Silvio Calderara · Neil Munro · Martin Whyte · Simon de Lusignan · Simon de Lusignan
Erratum to: Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study (Diabetes Therapy, (2018), 9, 1, (153-163), 10.1007/s13300-017-0349-1) Jun Lu · Hongtao Wang · Xueli Zhang · Xuemei Yu · Xuemei Yu
Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol Abdallah Y. Naser · Qian Wang · Lisa Y.L. Wong · Jenni Ilomäki · J. Simon Bell · Gang Fang · Ian C.K. Wong · Li Wei · Li Wei
Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes Naoto Katakami · Tomoya Mita · Mitsuyoshi Takahara · Kiyoshi Hashigami · Masaru Kawashima · Iichiro Shimomura · Hirotaka Watada · Hirotaka Watada
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study Cheli Melzer Cohen · Brian Larsen Thorsted · Michael Lyng Wolden · Gabriel Chodick · Avraham Karasik · Avraham Karasik
Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level Shana Traina · April Slee · Suzy Van Sanden · Joris Diels · Joris Diels
A Case of Maturity Onset Diabetes of the Young (MODY3) in a Family with a Novel HNF1A Gene Mutation in Five Generations Priscilla Hollander · Jie Liu · Julie S. Hill · Jeremy Johnson · Zhi Wei Jiang · Gregory T. Golm · Susan Huyck · Steven G. Terra · James P. Mancuso · Samuel S. Engel · Brett Lauring · Brett Lauring
Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For A. K. Ovsyannikova · O. D. Rymar · D. E. Ivanoshchuk · Svetlana V. Mikhailova · E. V. Shakhtshneider · P. S. Orlov · E. S. Malakhina · E. S. Malakhina · M. I. Voevoda · M. I. Voevoda
Hospital admissions due to dysglycaemia and prescriptions of antidiabetic medications in England and Wales: an ecological study René Rodríguez-Gutiérrez · Alejandro Salcido-Montenegro · José Gerardo González-González · José Gerardo González-González
Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden Abdallah Y. Naser · Qian Wang · Lisa Y.L. Wong · Jenni Ilomäki · J. Simon Bell · Gang Fang · Ian C.K. Wong · Li Wei · Li Wei
Peer Education Group Intervention to Reduce Psychological Insulin Resistance: A Pilot Mixed-Method Study in a Chinese Population Johan Jendle · Jayne Smith-Palmer · Alexis Delbaere · Simona de Portu · Natalie Papo · Wj Valentine · S Roze · S Roze
DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study Ka Yan Or · Benjamin Hoi-Kei Yip · Chi Hang Lau · Hing Han Chen · Yuk Wah Chan · Kam Pui Lee · Kam Pui Lee
An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin Niranjan Kathe · Anuj Shah · Qayyim Said · Jacob T. Painter · Jacob T. Painter
There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study Tomoe Kinoshita · Masashi Shimoda · Junpei Sanada · Yoshiro Fushimi · Yurie Hirata · Shintaro Irie · Atsushi Obata · Tomohiko Kimura · Hidenori Hirukawa · Kenji Kohara · Fuminori Tatsumi · Shinji Kamei · Shuhei Nakanishi · Tomoatsu Mune · Kohei Kaku · Hideaki Kaneto · Hideaki Kaneto
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study Hisamitsu Ishihara · Susumu Yamaguchi · Ikko Nakao · Taishi Sakatani · Taishi Sakatani
Diabetic Gastroparesis: Principles and Current Trends in Management Sathya Krishnasamy · Thomas L. Abell · Thomas L. Abell
Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Xia Dai · Zu-chun Luo · Lu Zhai · Wen-piao Zhao · Feng Huang · Feng Huang
Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study Analía Ramos · Fernanda Rabasa · Lilian Mendoza · Joana Cardenete · Pedro Gill · Alba Morilla · Daniel Cardona · Antonio Pérez · Antonio Pérez · Antonio Pérez
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK Richard F. Pollock · Wj Valentine · Steven P. Marso · Jens Gundgaard · Nino Hallén · Lars Hansen · Deniz Tutkunkardas · John B. Buse · John B. Buse
Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey Hiroki Murayama · Kota Imai · Masato Odawara · Masato Odawara
Treatment intensification in type 2 diabetes: A real-world study of 2-OAD regimens, GLP-1 RAs, or basal insulin Lawrence Blonde · Denis Raccah · Elisheva Lew · Juliana Meyers · Elena Nikonova · Mayank Ajmera · Keith L. Davis · Monica Bertolini · B. Guerci · B. Guerci
Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis Shuichi Suzuki · Urvi Desai · Alena Strizek · Jasmina I. Ivanova · Viviana Garcia-Horton · Zhihong Cai · Luke Schmerold · Xinyue Liu · Magaly Perez-Nieves · Magaly Perez-Nieves
The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study Yanjin Hu · Jia Liu · Guang Wang · Yuan Xu · Yuan Xu
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia Nebojsa Lalic · Monika Russel-Szymczyk · Marina Culic · Christian Klyver Tikkanen · Barrie Chubb · Barrie Chubb
Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial Tomoya Mita · Toru Hiyoshi · Hidenori Yoshii · Hiroko Chimori · Kazuo Ikeda · Junko Sato · Hirotaka Watada · Hirotaka Watada
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Anti-Diabetic Drugs Michal Witkowski · Lars Wilkinson · Neil Webb · Alan Weids · Divina Glah · Hrvoje Vrazic · Hrvoje Vrazic
A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin Michal Witkowski · Lars Wilkinson · Neil Webb · Alan Weids · Divina Glah · Hrvoje Vrazic · Hrvoje Vrazic
Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance Masakazu Haneda · Takashi Kadowaki · Hiroshi Ito · Kazuyo Sasaki · Sonoe Hiraide · Manabu Ishii · Miyuki Matsukawa · Makoto Ueno · Makoto Ueno
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus Riccardo Candido · Kathleen Wyne · Ester Romoli · Ester Romoli
Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Wei Chen · Yubin Wu · Yubao Hu · Yubao Hu
Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study Fumitaka Okajima · Yuko Nakamura · Yuji Yamaguchi · Yuki Shuto · Katsuhito Kato · Hitoshi Sugihara · Naoya Emoto · Naoya Emoto
A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs Yingping Yi · Yawei Li · Anran Hou · Yanqiu Ge · Yuan Xu · Gang Xiong · Xinlei Yang · Stephanie Ann Acevedo · Lizheng Shi · Hua Xu · Hua Xu
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis Ruixuan Jiang · Ernest H. Law · Zhou Zhou · Hongbo Yang · Eric Q. Wu · Raafat Seifeldin · Raafat Seifeldin
Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial Tingting Yin · Yan Bi · Ping Li · Shanmei Shen · Xiaolu Xiong · Li-Jun Gao · Can Jiang · Yan Wang · Wen-Huan Feng · Dalong Zhu · Dalong Zhu
A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study Tsuyoshi Okura · Kei Teramoto · Rie Koshitani · Yohei Fujioka · Yusuke Endo · Masaru Ueki · Masahiko Kato · Shin-ichi Taniguchi · Hiroshi Kondo · Kazuhiro Yamamoto · Kazuhiro Yamamoto
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss Maria J. Pereira · Per Lundkvist · Prasad G. Kamble · Joey Lau · Julian G. Martins · C. David Sjöström · Volker Schnecke · Anna Walentinsson · Eva Johnsson · Jan W. Eriksson · Jan W. Eriksson
Similar Intrapatient Blood Glucose Variability with LY2963016 and Lantus® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation Hiroshi Nishiyama · Tomotaka Shingaki · Yumi Suzuki · Liza L. Ilag · Liza L. Ilag
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study Akiko Nishimura · Shin-ichi Harashima · Kiminori Hosoda · Nobuya Inagaki · Nobuya Inagaki
Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons Chakrapani Balijepalli · Rohan Shirali · Prashanth Kandaswamy · Anastasia Ustyugova · Egon Pfarr · Søren S Lund · Eric Druyts · Eric Druyts
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis K.C.C. Petri · Steen H. Ingwersen · Anne Flint · Jeppe Zacho · Rune Viig Overgaard · Rune Viig Overgaard
Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review Zhihui Deng · John Davis · Flor Muniz-Rodriguez · Fran Richardson · Fran Richardson
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study Gian Paolo Fadini · Daniele Bottigliengo · Federica D’Angelo · Franco Cavalot · Antonio Carlo Bossi · Giancarlo Zatti · Ileana Baldi · Angelo Avogaro · Angelo Avogaro
Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population Fei Sun · Bin Gao · Li Wang · Ying Xing · Jie Ming · Jie Zhou · Jianfang Fu · Xiaomiao Li · Shaoyong Xu · Guocai Liu · Qiuhe Ji · Qiuhe Ji
Handling Insulin-Related Emotions Sanjay Kalra · Komal Verma · Komal Verma
Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis Andrew Uloko · Baba Maiyaki Musa · Mansur Ramalan · Ibrahim Gezawa · Fabian Puepet · Ayekame T. Uloko · Musa M. Borodo · Kabiru B. Sada · Kabiru B. Sada
Thoughts, Words, Action: The Alma-Ata Declaration to Diabetes Care Transformation Sanjay Kalra · Zhanay A. Akanov · Alex Y. Pleshkova · Alex Y. Pleshkova
Diabetes Fatigue Syndrome Sanjay Kalra · Rakesh Sahay · Rakesh Sahay
Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments W. Ryan Powell · Cindy L. Christiansen · Donald R. Miller · Donald R. Miller
Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis Qiang Wang · Hao Liu · Jiawang Ding · Jiawang Ding
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus Eveline Bruinstroop · Laura Meyer · Catherine B. Brouwer · Diana E. van Rooijen · P. Sytze van Dam · P. Sytze van Dam
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies Henry N. Ginsberg · Michel Farnier · Jennifer G. Robinson · Christopher P. Cannon · Naveed Sattar · Marie T. Baccara-Dinet · Alexia Letierce · Maja Bujas-Bobanovic · Michael J. Louie · Helen M. Colhoun · Helen M. Colhoun
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes Chantal Mathieu · Doina Catrinoiu · Aurelian Emil Ranetti · Eva Johnsson · Lars Hansen · Hungta Chen · Ricardo Garcia-Sanchez · Nayyar Iqbal · Aleksander Celiński · Aleksander Celiński
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects Valentin Demmel · Anne Sandberg-Schaal · Jacob Bonde Jacobsen · Georg Golor · Jonas Pettersson · Anne Flint · Anne Flint
Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial Sam Miller · Tania Krumins · Haojin Zhou · Susan Huyck · Jeremy Johnson · Gregory T. Golm · Steven G. Terra · James P. Mancuso · Samuel S. Engel · Brett Lauring · Brett Lauring
Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study Yukio Horikawa · Mayumi Enya · Makie Komagata · Ken-ichi Hashimoto · Masayo Kagami · Maki Fukami · Jun Takeda · Jun Takeda
Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Hitoshi Ishii · Hiroki Shin · Takahiro Tosaki · Tatsuya Haga · Yoshiki Nakajima · Toshihiko Shiraiwa · Nobuaki Watanabe · Miyuki Koizumi · Hiroki Nakajima · Sadanori Okada · Tsuyoshi Mashitani · Takako Mohri · Yasuhiro Akai · Yasuhiro Akai
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitor as an Add-on Drug to GLP-1 Receptor Agonists for Glycemic Control of a Patient with Prader–Willi Syndrome: A Case Report Hiroaki Ueno · Hiroko Nakazato · Emi Ebihara · Kenji Noma · Takahisa Kawano · Kazuhiro Nagamine · Hideyuki Sakoda · Masamitsu Nakazato · Masamitsu Nakazato
Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study Ariel Zisman · Terry Dex · Michelle Roberts · Aramesh Saremi · Jason Chao · Vanita R. Aroda · Vanita R. Aroda
Association of Vitamin D and Parathyroid Hormone with Insulin Sensitivity, Beta Cell Function and Gestational Diabetes in Pregnancy: A Cross-Sectional, Observational Study Natsu Otowa-Suematsu · Kazuhiko Sakaguchi · Tomoaki Nakamura · Kenta Hara · Minoru Kishi · Naoko Hashimoto · Kazuki Yokota · Hiroshi Yoshino · Yasuo Kuroki · Tomoko Nishiumi · Anna Sou · Hisako Komada · Yuko Okada · Yushi Hirota · Yoshikazu Tamori · Wataru Ogawa · Wataru Ogawa
Blood Glucose Monitoring and Its Determinants in Diabetic Patients: A Cross-Sectional Study in Shandong, China Amit Nachankar · Narendra Kotwal · Vimal Upreti · Vishesh Verma · K. V. S. Hari Kumar · K. V. S. Hari Kumar
Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar Abdul Marouf Raoufi · Xue Tang · Zhengyue Jing · Xinyi Zhang · Qiongqiong Xu · Chengchao Zhou · Chengchao Zhou
Living with Type 2 Diabetes: Patient Commentary in Response to the Paper SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice Goran Petrovski · Fawziya Al Khalaf · Khalid Hussain · Judith Campbell · Ahmed El Awwa · Ahmed El Awwa
Pediatric Insulin Injection Technique: A Multi-Country Survey and Clinical Practice Implications A Patient from Diabetes Uk · Marc Evans · Marc Evans
Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis Sanjay Kalra · Laurence J. Hirsch · Anders Frid · Asthma Deeb · Kenneth Strauss · Kenneth Strauss
Could Intensive Blood Pressure Control Really Reduce Diabetic Retinopathy Outcomes? Evidence from Meta-Analysis and Trial Sequential Analysis from Randomized Controlled Trials Xiaoling Cai · Xueying Gao · Wenjia Yang · Xueyao Han · Linong Ji · Linong Ji
Long-Term Effects of Oral Antidiabetic Drugs During Pregnancy on Offspring: A Systematic Review and Meta-analysis of Follow-up Studies of RCTs Jian-Bo Zhou · Zhi-Hui Song · Lu Bai · Xiao-Rong Zhu · Hong-bing Li · Jin-Kui Yang · Jin-Kui Yang
Male Patients with Longstanding Type 2 Diabetes Have a Higher Incidence of Hypoglycemia Compared with Female Patients Wenneke van Weelden · Vincent Wekker · Leon de Wit · Jacqueline Limpens · Hilkka Ijäs · Aleid van Wassenaer-Leemhuis · Tessa J. Roseboom · Bas B. van Rijn · J. Hans DeVries · Rebecca C. Painter · Rebecca C. Painter
Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis Feng-fei Li · Ying Zhang · Wen-li Zhang · Xiao-mei Liu · Mao-yuan Chen · Yi-xuan Sun · Xiao-fei Su · Jin-dan Wu · Lei Ye · Jianhua Ma · Jianhua Ma
Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis Manjiri Pawaskar · Liou Xu · Yuexin Tang · Gary Puckrein · Swapnil Rajpathak · Bruce Stuart · Bruce Stuart
Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm Pei-Jung Lin · E Pope · Fang Liz Zhou · Fang Liz Zhou
Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM) Masahiko Miyagi · Hiroshi Uchino · Naoki Kumashiro · Mariko Higa · Koki Shin · Makiko Sasamoto · Hiroji Kitazato · Motoyuki Tamaki · Munehide Matsuhisa · Takahisa Hirose · Takahisa Hirose
Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale Jan Brož · Denisa Janíčková Žďárská · Jana Urbanová · Marek Brabec · Viera Doničová · Radka Štěpánová · Emil Martinka · Milan Kvapil · Milan Kvapil
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting Yoshiaki Kubota · Takeshi Yamamoto · Shuhei Tara · Yukichi Tokita · Kenji Yodogawa · Yuki Iwasaki · Hitoshi Takano · Yayoi Tsukada · Kuniya Asai · Masaaki Miyamoto · Yasushi Miyauchi · Eitaro Kodani · Naoki Sato · Jun Tanabe · Wataru Shimizu · Wataru Shimizu
Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios Marc Evans · Roopa Mehta · Jens Gundgaard · Barrie Chubb · Barrie Chubb
Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L Ian J. Neeland · Darren K. McGuire · Björn Eliasson · Martin Ridderstråle · Cordula Zeller · Hans J. Woerle · Uli C. Broedl · Odd Erik Johansen · Odd Erik Johansen
Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study (Diabetes Therapy, (2015), 6, 4, (635-642), 10.1007/s13300-015-0146-7) Jennifer Goldman · Jasvinder Gill · Tony Horn · Timothy Reid · Jodi Strong · William H. Polonsky · William H. Polonsky
Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program Vera Frison · Natalino Simioni · Alberto Marangoni · Sara Balzano · Carmela Vinci · Luciano Zenari · Lorena De Moliner · Federica Tadiotto · Michele D’Ambrosio · Loris Confortin · Narciso Marin · Simonetta Lombardi · Silvana Costa · Giuseppe Prosperini · Annunziata Lapolla · Annunziata Lapolla
The Trend of High-Dose Insulin Usage Among Patients with Diabetes in the UK: A Retrospective Study Weiheng Wen · Peili Wu · Jinru Gong · Min Zhao · Zhen Zhang · Rongping Chen · Hong Chen · Jia Sun · Jia Sun
Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study Peter Wiesli · Marcus Schories · Marcus Schories
Effects of Insulin Degludec and Insulin Glargine U300 on Day-to-Day Fasting Plasma Glucose Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study (Kobe Best Basal Insulin Study 2) Maja Baretić · Vesna Kušec · Ivana Pavlić-Renar · Ivana Pavlić-Renar
Insulin Injection Technique is Associated with Glycemic Variability in Patients with Type 2 Diabetes Hiroshi Miura · Kazuhiko Sakaguchi · Yuko Okada · Natsu Otowa-Suematsu · Tomoko Yamada · Anna So · Hisako Komada · Yushi Hirota · Minoru Kishi · Akihiko Takeda · Yoichi Tominaga · Tomoaki Nakamura · Yasuo Kuroki · Tomokazu Matsuda · Keiji Iida · Michiko Kajikawa · Takeshi Ohara · Kazuki Yokota · Kenta Hara · Sanshiro Tateya · Yoshikazu Tamori · Wataru Ogawa · Wataru Ogawa
Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus Lu Yuan · Feng-fei Li · Ting Jing · Bo Ding · Yong Luo · Rui Sun · Xiuping Wang · Hefeng Diao · Xiao-fei Su · Lei Ye · Jianhua Ma · Jianhua Ma
Investigating the Reliability of HbA1c Monitoring for Blood Glucose Control During Late Pregnancy in Patients with Gestational Diabetes Mellitus (GDM) with and without β-Thalassemia Minor Yuexin Tang · Jinan Liu · Hakima Hannachi · Samuel S. Engel · Michael L. Ganz · Swapnil Rajpathak · Swapnil Rajpathak
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany Xueqin Zhang · Yunshan Xiao · Yanfeng Fan · Yanfeng Fan
Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study Focke Ziemssen · Joachim Wachtlin · Laura Kuehlewein · Maria-Andreea Gamulescu · Thomas Bertelmann · N. Feucht · Jessica Voegeler · Mirja Koch · Sandra Liakopoulos · Steffen Schmitz-Valckenberg · Georg Spital · Georg Spital
Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System Iskandar Idris · Xiaomei Peng · Xuanyao He · Dongju Liu · Elemer Balogh · Puneet Kaushik · Kate Van Brunt · Kate Van Brunt
Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study Xia Dai · Zu-chun Luo · Lu Zhai · Wen-piao Zhao · Feng Huang · Feng Huang
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis Yong Luo · Xue-qin Wang · Wen-ji Ni · Bo Ding · Xianghong Xu · Lei Ye · Jianhua Ma · Jian Zhu · Jian Zhu
A Prospective Cohort Study on the Management of Young Patients with Newly Diagnosed Type 2 Diabetes Using Mobile Medical Applications Stephen M. Twigg · Javier Escalada · Javier Escalada · Peter Stella · Ana Merino-Trigo · Fernando Javier Lavalle-González · Bertrand Cariou · Luigi Meneghini · Luigi Meneghini
Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety Yabin Hao · Hong Xu · Hong Xu
Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward? Paola Ponzani · Cesare Berra · Alessandra Di Lelio · Paola Del Sindaco · Chiara Di Loreto · Francesco Reggiani · Giuseppe Lucisano · Maria Chiara Rossi · Maria Chiara Rossi
Diabetes and Diet: A Patient and Dietitians Perspective Harriet Warnes · Rebecca Helliwell · Sam Matthew Pearson · Sam Matthew Pearson · Ramzi Ajjan · Ramzi Ajjan · Ramzi Ajjan
Impact of Glucose Measuring Systems and Sample Type on Diagnosis Rates of Diabetes Mellitus Carole Sergeant · Pamela Dyson · Pamela Dyson
Reassessing Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus: A Brief Updated Analytical Report (2015–2017) Markus Gabriel Blaurock · Anders Kallner · Stefan Menzel · Annette Masuch · Matthias Nauck · Astrid Petersmann · Astrid Petersmann
Patients Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography Fernando Gomez-Peralta · Cristina Abreu · Sara Gomez-Rodriguez · Rafael J. Barranco · Guillermo E. Umpierrez · Guillermo E. Umpierrez
Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis Aikaterini Psarou · Helen Cooper · John Wilding · John Wilding
Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians Perspective in a Real-World Setting, Insight from a Web Survey Dan Qian · Tiantian Zhang · Peiying Zheng · Zhuoru Liang · Sen Wang · Jingmei Xie · Lina Zhao · Ying Zhang · Bing Situ · Bing Situ
Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment Denisa Janíčková Žďárská · Martin Hill · Milan Kvapil · Piťhová P · Jan Brož · Jan Brož
Diabetes in the Elderly Tianwei Gu · Ting Hong · Pengzi Zhang · Sunyinyan Tang · Yan Bi · Hai Lu · Lichuang Men · Dongwei Ma · Dalong Zhu · Dalong Zhu
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes Sanjay Kalra · Suresh K. Sharma · Suresh K. Sharma
Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population Lori Berard · Noreen Antonishyn · Kathryn Arcudi · Sarah Blunden · Alice Cheng · Ronald Goldenberg · Stewart B. Harris · Shelley L. Jones · Upender Mehan · James Morrell · Robert Roscoe · Rick Siemens · Michael Vallis · Jean-François Yale · Jean-François Yale
Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes Kristina S. Boye · Fady T. Botros · Axel Haupt · Brad Woodward · Maureen J. Lage · Maureen J. Lage
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes Steven P. Marso · Elise Hardy · Jenny Han · Hui Wang · Robert Chilton · Robert Chilton
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis Atsutaka Yasui · Ganghyuck Lee · Tetsuaki Hirase · Tatsuroh Kaneko · Stefan Kaspers · Maximilian von Eynatten · Tomoo Okamura · Tomoo Okamura
Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic Yue Gao · Ke Wang · Yun Chen · Li Shen · Jianing Hou · Jianwei Xuan · Bao Liu · Bao Liu
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States Naoto Katakami · Tomoya Mita · Hidenori Yoshii · Toshihiko Shiraiwa · Tetsuyuki Yasuda · Yosuke Okada · Yutaka Umayahara · Hideaki Kaneto · Takeshi Osonoi · Tsunehiko Yamamoto · Nobuichi Kuribayashi · Kazuhisa Maeda · Hiroki Yokoyama · Keisuke Kosugi · Kentaro Ohtoshi · Isao Hayashi · Satoru Sumitani · Mamiko Tsugawa · Makoto Ohashi · Hideki Taki · Tadashi Nakamura · Satoshi Kawashima · Yasunori Sato · Hirotaka Watada · Iichiro Shimomura · Iichiro Shimomura
Changing Patients Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial Panwei Mu · De-zhao Liu · Ying Lin · Dong Liu · Fan Zhang · Yong-jun Zhang · Shuo Lin · Lin-qin Wang · Manman Wang · Jiong Shu · Longyi Zeng · Yanming Chen · Yanming Chen
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study C. Neslusan · M. Willis · Pierre Johansen · Lien Vo · Lien Vo
Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections Sarah Hallberg · Amy L. McKenzie · Paul T. Williams · Nasir H. Bhanpuri · Anne L. Peters · Wayne W. Campbell · Tamara L. Hazbun · Brittanie M. Volk · James P. McCarter · Stephen D. Phinney · Jeff S. Volek · Jeff S. Volek
Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch Karolina Jabłońska · Piotr Molęda · Krzysztof Safranow · Lilianna Majkowska · Lilianna Majkowska
Serum Bilirubin Concentration is Associated with Left Ventricular Remodeling in Patients with Type 2 Diabetes Mellitus: A Cohort Study Mark Peyrot · Darlene M. Dreon · Vivien Zraick · Brett Cross · Meng H. Tan · Meng H. Tan
Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database Tomoaki Inoue · Noriyuki Sonoda · Shinsuke Hiramatsu · Shinichiro Kimura · Yoshihiro Ogawa · Yoshihiro Ogawa · Toyoshi Inoguchi · Toyoshi Inoguchi
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study Tongtong Wang · Ann Marie McNeill · Yong Chen · Yong Chen · Edward A. O’Neill · Samuel S. Engel · Samuel S. Engel
Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study Christopher Ll. Morgan · Qing Qiao · Susan Grandy · Kristina Johnsson · Sara Jenkins-Jones · Sarah E. Holden · Craig John Currie · Craig John Currie
Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response Robert A. Bailey · Alicia C. Shillington · Qing Harshaw · Martha M. Funnell · Jeffrey VanWingen · Nananda Col · Nananda Col
The Postprandial to Fasting Serum C-peptide Ratio is a Predictor of Response to Basal Insulin Supported Oral Antidiabetic drug(s) therapy: A Retrospective Analysis Sarah Hallberg · Amy L. McKenzie · Paul T. Williams · Nasir H. Bhanpuri · Anne L. Peters · Wayne W. Campbell · Tamara L. Hazbun · Brittanie M. Volk · James P. McCarter · Stephen D. Phinney · Jeff S. Volek · Jeff S. Volek
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients Kota Imai · Hiroki Murayama · Takahisa Hirose · Takahisa Hirose
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea Goran Petrovski · Fawziya Al Khalaf · Khalid Hussain · Judith Campbell · Judith Campbell
Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study Kathryn M. Pfeiffer · Amaury Basse · Xin Ying Lee · Laura Tesler Waldman · Laura Tesler Waldman
Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy György Jermendy · Zoltán Kiss · György Rokszin · Zsolt Abonyi-Tóth · István Wittmann · P. Kempler · P. Kempler
A Systematic Review of Ultrasound-Detected Lipohypertrophy in Insulin-Exposed People with Diabetes Ting Chen · Dandan Zhang · Zhenjiang Bai · Shuiyan Wu · Haiying Wu · Rongrong Xie · Ying Li · Fengyun Wang · Xiuli Chen · Hui Sun · Xiaoyan Wang · Linqi Chen · Linqi Chen
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice Haya Abu Ghazaleh · Rabab Hashem · Angus Forbes · Thandiwe Rebecca Dilwayo · Maria Duaso · Jackie Sturt · Susan Halson-Brown · Henrietta Mulnier · Henrietta Mulnier
Durability of Glucose-Lowering Effect of the First Administration of Dulaglutide: A Retrospective, Single-Center, Single-Arm Study John Wilding · Kevin Fernando · Nicola Milne · Marc Evans · Amar Ali · S. C. Bain · Debbie Hicks · June James · Philip Newland-Jones · Dipesh Patel · Adie Viljoen · Adie Viljoen
Association Trends Between Antihypertensive Drug Therapies and Diastolic Hypotension in Emirati Patients with Type 2 Diabetes: A Single-Center Retrospective Longitudinal Study Maya Matsushita · Daisuke Chujo · Mie Tonoike · Hiroshi Kajio · Hiroshi Kajio
Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report Bashair M. Mussa · Rifat Hamoudi · Salah E. Abusnana · Salah E. Abusnana
The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis Eugene Han · Ari Kim · Sung Jae Lee · Je-Yon Kim · Jae Hyeon Kim · Woo Je Lee · Byung-Wan Lee · Byung-Wan Lee
Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Yan Duan · Jia Liu · Yuan Xu · Ning Yang · Wenying Yang · Guang Wang · Guang Wang
Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project Chenfang Wu · Diling Wu · Minjie Lin · Yanjun Zhong · Yanjun Zhong
Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study Muhammad Ali Karamat · Shujah Dar · Srikanth Bellary · Abd A. Tahrani · Abd A. Tahrani
Herpes Zoster and Diabetes Mellitus: A Review Lucine Halepian · Mary Bou Saleh · Souheil Hallit · Lydia Rabbaa Khabbaz · Lydia Rabbaa Khabbaz
Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions Marianthi Papagianni · Symeon Metallidis · Konstantinos Tziomalos · Konstantinos Tziomalos
Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial Gian Paolo Fadini · Mayur Sarangdhar · Angelo Avogaro · Angelo Avogaro
Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial Wei Li · Fan Ping · Lingling Xu · Meicen Zhou · Hongmei Li · Yaxiu Dong · Yuxiu Li · Yuxiu Li
Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial Qing Su · Jun Liu · Peng Fei Li · Lei Qian · Wen Ying Yang · Wen Ying Yang
The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System Witesh Parekh · Sophie E. Streeton · James Baker-Knight · Roberta Montagnoli · Paolo Nicoziani · Giulio Marchesini · Giulio Marchesini
Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland Lingling Xu · Xiaopu Lin · Meiping Guan · Yingshan Liu · Yingshan Liu
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries Martin Haluzik · Adam Kretowski · Krzysztof Strojek · Leszek Czupryniak · Andrej Janez · P. Kempler · Michal Andel · Tsvetalina Tankova · Mihail Boyanov · Lea Duvnjak · László Madácsy · Iwona Tarnowska · Marcin Zychma · Nebojsa Lalic · Nebojsa Lalic
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States Lars Wilkinson · Barnaby Hunt · Pierre Johansen · Neeraj N. Iyer · Tam Dang-Tan · Richard F. Pollock · Richard F. Pollock
Adverse Drug Events Associated with Low-Dose (10 mg) Versus High-Dose (25 mg) Empagliflozin in Patients Treated for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Xia Dai · Zu-chun Luo · Lu Zhai · Wen-piao Zhao · Feng Huang · Feng Huang
Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies Takashi Kadowaki · Kazuyo Sasaki · Manabu Ishii · Miyuki Matsukawa · Yoshiteru Ushirogawa · Yoshiteru Ushirogawa
Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes Sanjay Kalra · Anu Gupta · Anu Gupta
User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors Guido Freckmann · Nina Jendrike · Annette Baumstark · Stefan Pleus · Christina Liebing · Cornelia Haug · Cornelia Haug
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study Xin Qian · Hui Wang · Gangyi Yang · Zhengnan Gao · Yong Luo · Aimei Dong · Fang Zhang · Mingtong Xu · Shiping Liu · Xin Yang · Yanyan Chen · Guangwei Li · Guangwei Li
A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes Neil Webb · Michelle Orme · Michal Witkowski · Rie Nakanishi · Jakob Langer · Jakob Langer
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study Marco Orsini Federici · Janette McQuillan · Giovanni Biricolti · Serena Losi · Jeremie Lebrec · Catrina Richards · Cristiana Miglio · Kirsi Norrbacka · Kirsi Norrbacka
Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review J. Jerry Meece · J. Jerry Meece
Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study Robyn K. Pollom · Timothy M. Costigan · Lyndon B. Lacaya · Liza L. Ilag · Priscilla A. Hollander · Priscilla A. Hollander
EADSG Guidelines: Insulin Therapy in Diabetes Bahendeka Silver · Kaushik Ramaiya · Swai Babu Andrew · Otieno Fredrick · Sarita Bajaj · Sanjay Kalra · Bavuma M. Charlotte · Karigire Claudine · Anthony Makhoba · Anthony Makhoba
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol William Hinton · Michael D Feher · Neil Munro · Simon de Lusignan · Simon de Lusignan
Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis Kirsten Nørgaard · Nithya Sukumar · Snorri Bjorn Rafnsson · Ponnusamy Saravanan · Ponnusamy Saravanan
Prediabetes Directly Deteriorates into Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome Triggered by Acute Pancreatitis: A Case Report Illustrating aChicken and EggParadigm in Ketosis-Prone Diabetes Runbo Song · Shanjin Cao · Shanjin Cao
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk Edison Goncalves · David S. H. Bell · David S. H. Bell
Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis Feng Huang · Feng Huang
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA Lawrence Blonde · Luigi Meneghini · Xuejun Victor Peng · Anders Boss · Kyu Rhee · Alka Shaunik · Supriya Kumar · Sidhartha Balodi · Claire Brulle-Wohlhueter · Rory J. McCrimmon · Rory J. McCrimmon
Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study Avi Porath · Naama Fund · Yasmin Maor · Yasmin Maor
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes Araceli Munoz-Garach · Maria Molina-Vega · Francisco J. Tinahones · Francisco J. Tinahones
Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study Jochen Sieber · Frank Flacke · Manuela Link · Cornelia Haug · Guido Freckmann · Guido Freckmann
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes Wan Mohamaed Wan Bebakar · Louis Chaykin · Malene Lundgren Hersløv · Søren Rasmussen · Søren Rasmussen
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study Peter Eibich · Amelia Green · Andrew T. Hattersley · Christopher Jennison · Mike Lonergan · Ewan R. Pearson · Alastair Gray · Alastair Gray
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study Yuli Cai · Tianshu Zeng · Zhongyuan Wen · Lulu Chen · Lulu Chen
Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes Virginia Valentine · Jennifer Goldman · Jay H. Shubrook · Jay H. Shubrook
Visceral Adipose Tissue as a Risk Factor for Diabetes Mellitus in Patients with Chronic Pancreatitis: A Cross-sectional, Observational Study Witesh Parekh · Nicki Hoskins · James Baker-Knight · Antonio Ramírez de Arellano · Pedro Mezquita Raya · Pedro Mezquita Raya
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus John E. Anderson · Eugene E. Wright · Charles F. Shaefer · Charles F. Shaefer
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life Valentina Fattorusso · Alida Casale · Valeria Raia · Enza Mozzillo · Adriana Franzese · Adriana Franzese
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes Fernando Gomez-Peralta · Cristina Abreu · Albert Lecube · Diego Bellido · Alfonso Soto · Cristóbal Morales · Miguel Brito-Sanfiel · Guillermo E. Umpierrez · Guillermo E. Umpierrez
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial Sultan Linjawi · Bruce W. Bode · Louis Chaykin · Jean-Pierre Courrèges · Yehuda Handelsman · Lucine Lehmann · Abhishek Mishra · Richard W. Simpson · Richard W. Simpson
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes Fernando Gomez-Peralta · Cristina Abreu · Albert Lecube · Diego Bellido · Alfonso Soto · Cristóbal Morales · Miguel Brito-Sanfiel · Guillermo E. Umpierrez · Guillermo E. Umpierrez
Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan Irene Hadjiyianni · Urvi Desai · Shuichi Suzuki · Jasmina I. Ivanova · Dachuang Cao · Noam Y. Kirson · Dai Chida · Caroline J. Enloe · Howard G. Birnbaum · Magaly Perez-Nieves · Magaly Perez-Nieves
Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S) Takuya Awata · Akira Shimada · Taro Maruyama · Yoichi Oikawa · Nobuyuki Yasukawa · Susumu Kurihara · Yumi Miyashita · Masako Hatano · Yuichi Ikegami · Masafumi Matsuda · Masataka Niwa · Youichiro Kazama · Shoichiro Tanaka · Tetsuro Kobayashi · Tetsuro Kobayashi
Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden Johan Jendle · Åsa Ericsson · Barnaby Hunt · Wj Valentine · Richard F. Pollock · Richard F. Pollock
Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study Ayman A. Al Hayek · Asirvatham Alwin Robert · Saleha Babli · Khuloud Almonea · Mohamed Abdulaziz Al Dawish · Mohamed Abdulaziz Al Dawish
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial Thomas Haak · H. Hanaire · Ramzi Ajjan · Norbert Hermanns · Jean-Pierre Riveline · Gerry Rayman · Gerry Rayman
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial Feng-fei Li · Lanlan Jiang · Li-yuan Fu · Hong-hong Zhu · Peihua Zhou · Dan-feng Zhang · Xiao-fei Su · Jin-dan Wu · Lei Ye · Jian-hua Ma · Jian-hua Ma
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis Maria Lorenzi · U.J. Ploug · Jakob Langer · Rasmus Skovgaard · Michael Zoratti · Jeroen P. Jansen · Jeroen P. Jansen
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review Cody D. Black · Wade Thompson · Vivian Welch · Vivian Welch · Lisa McCarthy · Lisa McCarthy · Carlos Rojas-Fernandez · Heather Lochnan · Heather Lochnan · Salima Shamji · Ross Upshur · Barbara Farrell · Barbara Farrell · Barbara Farrell
Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom Barnaby Hunt · Qing Ye · Wj Valentine · Donna Ashley · Donna Ashley
The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study Sanja Klobučar Majanović · Andrej Janez · Ivaylo N Lefterov · Sanja Tasic · Tatjana Cikac · Tatjana Cikac
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries Victoria Divino · Mitch DeKoven · Farhad Ali Khan · Kristina S. Boye · Hélène Sapin · Kirsi Norrbacka · Kirsi Norrbacka
Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data Kohei Kaku · Michael Lyng Wolden · Jacob Hyllested-Winge · Emil Nørtoft · Emil Nørtoft
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol) Andrew McGovern · Michael D. Feher · Neil Munro · Simon de Lusignan · Simon de Lusignan
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study Xiaomeng Feng · Xia Gao · Yumei Jia · Heng Zhang · Yuan Xu · Yuan Xu
Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study Kunihiro Suzuki · Chie Aoki · Kanako Kato · Masanori Shimizu · Shintaro Sakurai · Kazunori Yanagi · Hisamoto Kuroda · Yoshimasa Aso · Yoshimasa Aso
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain Yoko Irie · Naoto Katakami · Tomoya Mita · Mitsuyoshi Takahara · Taka-aki Matsuoka · Masahiko Gosho · Hirotaka Watada · Iichiro Shimomura · Iichiro Shimomura
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study Maria J. Peláez-Jaramillo · Allison A. Cárdenas-Mojica · Paula V. Gaete · Carlos O. Mendivil · Carlos O. Mendivil
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens Li Xin Shi · Peng Fei Li · Jia Ning Hou · Jia Ning Hou
Improving Self-Management of Type 2 Diabetes in Overweight and Inactive Patients Through an Educational and Motivational Intervention Addressing Diet and Physical Activity: A Prospective Study in Naples, South Italy F. Gallè · Valeria Di Onofrio · Assunta Cirella · Mirella Di Dio · Alessandra Miele · Tiziana Spinosa · G. Liguori · G. Liguori
Resistance Training for Glycemic Control, Muscular Strength, and Lean Body Mass in Old Type 2 Diabetic Patients: A Meta-Analysis Junghoon Lee · Do-Houn Kim · ChangKeun Kim · ChangKeun Kim
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials Mikaela Sjöstrand · Cheryl Wei · William Cook · Kristina Johnsson · Pia S. Pollack · Christina Stahre · Boaz Hirshberg · Boaz Hirshberg
Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes Thomas Haak · H. Hanaire · Ramzi Ajjan · Norbert Hermanns · Jean-Pierre Riveline · Gerry Rayman · Gerry Rayman
The Impact of Frequency and Tone of Parent–Youth Communication on Type 1 Diabetes Management Mark D. DeBoer · Rupa Valdez · Daniel Chernavvsky · Monica Grover · Christine M Burt Solorzano · Kirabo Herbert · Stephen D. Patek · Stephen D. Patek
Comment on the New Indian Injection Technique Recommendations: Critical Appraisal of the Real-World Implementation of the Current Guidelines Felice Strollo · Sandro Gentile · Sandro Gentile
A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach S. C. Christiansen · Anders Lyngvi Fougner · Anders Lyngvi Fougner · Øyvind Stavdahl · Konstanze Kölle · Konstanze Kölle · Reinold Ellingsen · Sven M. Carlsen · Sven M. Carlsen
A Practical Review of C-Peptide Testing in Diabetes Emma Leighton · Christopher A. R. Sainsbury · Gregory C. Jones · Gregory C. Jones
An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin Abdelmjid Chraibi · Shoorook Al-Herz · Bich Dao Nguyen · Djoko W. Soeatmadji · Anil Shinde · Balasubramanian Lakshmivenkataraman · Samir H. Assaad-Khalil · Samir H. Assaad-Khalil
Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands Barnaby Hunt · Divina Glah · Maarten van der Vliet · Maarten van der Vliet
The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis Tomoya Mita · Naoto Katakami · Toshihiko Shiraiwa · Hidenori Yoshii · Masahiko Gosho · Hitoshi Ishii · Iichiro Shimomura · Hirotaka Watada · Spike Trial Site Investigators · Spike Trial Site Investigators
Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial Ryo Iga · Hiroshi Uchino · Ken Kanazawa · Shuki Usui · Masahiko Miyagi · Naoki Kumashiro · Hiroshi Yoshino · Yasuyo Ando · Takahisa Hirose · Takahisa Hirose
Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management Satish K. Garg · Viral N. Shah · Halis K. Akturk · Christie Beatson · Janet K. Snell-Bergeon · Janet K. Snell-Bergeon
A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control Ira Gantz · Taro Okamoto · Yuka Ito · Asako Sato · Kotoba Okuyama · Edward A. O’Neill · Samuel S. Engel · Eseng Lai · Eseng Lai
Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study Natalino Simioni · Alessio Filippi · Marco Scardapane · Antonio Nicolucci · Maria Chiara Rossi · Vera Frison · Vera Frison
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis Elena Filipova · Katya Uzunova · Krassimir Kalinov · Toni Yonkov Vekov · Toni Yonkov Vekov
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study Tatsuya Fukuda · Ryotaro Bouchi · Masahiro Terashima · Yuriko Sasahara · Masahiro Asakawa · Takato Takeuchi · Yujiro Nakano · Masanori Murakami · Isao Minami · Hajime Izumiyama · Koshi Hashimoto · Takanobu Yoshimoto · Yoshihiro Ogawa · Yoshihiro Ogawa · Yoshihiro Ogawa
Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study Shi Bu · Xuelian Zhang · Haiqing Zhu · Ying Shuai · Xiaoyan Xing · Wenying Yang · Wenying Yang
Hypoglycemic Event Frequency and the Effect of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Using Multiple Daily Insulin Injections Tonya D. Riddlesworth · David Price · Nathan Cohen · Roy W. Beck · Roy W. Beck
Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes Kathryn Evans Kreider · Kathryn Evans Kreider
Skin Deep: Enhanced Variable May Help Explain Racial Disparities in Type 2 Diabetes and Prediabetes Celia C. Lo · Joanna Lara · Tyrone C. Cheng · Tyrone C. Cheng
Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis Weihao Wang · Hongyan Liu · Shumin Xiao · Shuaihui Liu · Xin Li · Pei Yu · Pei Yu
Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014 Ginger Carls · Johnny Huynh · Edward Tuttle · John Yee · Steven V. Edelman · Steven V. Edelman
Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc Analysis Helmut Brath · Päivi M. Paldánius · Giovanni Bader · Chantal Mathieu · Chantal Mathieu
The Economic Burden of Insulin-Related Hypoglycemia in Spain Witesh Parekh · Nicki Hoskins · James Baker-Knight · Antonio Ramírez de Arellano · Pedro Mezquita Raya · Pedro Mezquita Raya
Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM) Mihoko Matsumura · Yuki Nakatani · Seiichi Tanka · Chie Aoki · Masaaki Sagara · Kazunori Yanagi · Kunihiro Suzuki · Yoshimasa Aso · Yoshimasa Aso
Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial Xiuying Zhang · Zhiwei Fang · Chunfang Zhang · Huihua Xia · Zhuye Jie · Xueyao Han · Yingli Chen · Linong Ji · Linong Ji
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures Valentina Scattolini · Camilla Luni · Camilla Luni · Alessandro Zambon · Silvia Galvanin · Onelia Gagliano · Catalin Dacian Ciubotaru · Angelo Avogaro · Fabio Mammano · Nicola Elvassore · Gian Paolo Fadini · Gian Paolo Fadini
Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes Feng-fei Li · Yun Shen · Rui Sun · Dan-feng Zhang · Xing Jin · Xiao-fang Zhai · Mao-yuan Chen · Xiao-fei Su · Jin-dan Wu · Lei Ye · Jian-hua Ma · Jian-hua Ma
Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study Zhou Zhou · Paresh Chaudhari · Hongbo Yang · Anna P. Fang · Jing Zhao · Ernest H. Law · Eric Q. Wu · Ruixuan Jiang · Raafat Seifeldin · Raafat Seifeldin
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study Akiko Nishimura · Shin-ichi Harashima · Haruna Fukushige · Yu Wang · Yanyan Liu · Kiminori Hosoda · Nobuya Inagaki · Nobuya Inagaki
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom Lei Qin · Stephanie Chen · Emuella Flood · Alka Shaunik · Beverly Romero · Marie de la Cruz · Cynthia Alvarez · Susan Grandy · Susan Grandy
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis S. Kay · Amanda Strickson · Jorge Puelles · Ross Selby · Eugene Benson · Keith Tolley · Keith Tolley
The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus Irini P. Chatziralli · Irini P. Chatziralli
Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK Nandu Thalange · Natalie Aldhouse · Helen Kitchen · Daniel Howard · Deniz Tutkunkardas · Jonas Håkan-Bloch · Jonas Håkan-Bloch
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom Michael D Feher · Gabriela Vega-Hernandez · Emina Mocevic · Brian Buysse · Melissa Myland · Geraldine S. Power · Lise Lotte Husemoen · Joseph L. Kim · Daniel R. Witte · Daniel R. Witte
Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education Teresa H. Truong · Trang T. Nguyen · Becky L. Armor · Jamie R. Farley · Jamie R. Farley
Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional Sanjay Kalra · Ambrish Mithal · Rakesh Sahay · Mathew John · Ag Unnikrishnan · Banshi Saboo · Sujoy Ghosh · Debmalya Sanyal · Laurence J. Hirsch · Vandita Gupta · Kenneth W. Strauss · Kenneth W. Strauss
Indian Injection Technique Study: Population Characteristics and Injection Practices Sanjay Kalra · Ambrish Mithal · Rakesh Sahay · Mathew John · Ag Unnikrishnan · Banshi Saboo · Sujoy Ghosh · Debmalya Sanyal · Laurence J. Hirsch · Vandita Gupta · Kenneth W. Strauss · Kenneth W. Strauss
The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study So Ra Kim · So Ra Kim · Yong-ho Lee · Yong-ho Lee · Eun Seok Kang · Eun Seok Kang · Bong Soo Cha · Bong Soo Cha · Byung-Wan Lee · Byung-Wan Lee · Byung-Wan Lee
IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting Barnaby Hunt · Michelle Mocarski · Wj Valentine · Jakob Langer · Jakob Langer
PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study Xiaomeng Feng · Xia Gao · Yumei Jia · Yuan Xu · Yuan Xu
Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus® Insulin Glargine Liza L. Ilag · Timothy M. Costigan · Mark A. Deeg · Robyn K. Pollom · Curtis Chang · Robert J. Konrad · Melvin J. Prince · Melvin J. Prince
Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus Marc Evans · Barrie Chubb · Jens Gundgaard · Jens Gundgaard
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program Kamlesh Khunti · Viswanathan Mohan · Sunil M Jain · Trine Welløv Boesgaard · Kamilla Begtrup · Bipin Sethi · Bipin Sethi
Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients Jürgen Harreiter · Lana Kosi-Trebotic · Albert Lukas · Peter Wolf · Yvonne Winhofer · Anton Luger · Alexandra Kautzky-Willer · Michael Krebs · Michael Krebs
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK Gabriela Vega-Hernandez · Radek Wojcik · Max Schlueter · Max Schlueter
Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study Yujing Jin · Xiaowei Sun · Xichen Zhao · Tiehong Zhu · Tiehong Zhu
Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use Andrew McGovern · Michael D Feher · Neil Munro · Simon de Lusignan · Simon de Lusignan
Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study Rients van Wijngaarden · Jetty A. Overbeek · Edith M. Heintjes · A Schubert · Joris Diels · Huub Straatman · Ewout W. Steyerberg · Ron M. C. Herings · Ron M. C. Herings
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study Lei Qin · Stephanie Chen · Emuella Flood · Alka Shaunik · Beverly Romero · Marie de la Cruz · Cynthia Alvarez · Susan Grandy · Susan Grandy
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report Yuko Matsumoto · Hodaka Yamada · Shunsuke Funazaki · Daisuke Suzuki · Masafumi Kakei · Kazuo Hara · Kazuo Hara
A Practical Approach to Managing Hypoactive Sexual Desire Disorder in Women with Diabetes Charmaine Rochester-Eyeguokan · Lisa T. Meade · Lisa T. Meade
A Practical Approach to Hypertension Management in Diabetes Altamash Shaikh · Altamash Shaikh
Systemic effects of repeated intraocular dexamethasone Intravitreal implant in diabetic patients: a retrospective study Alicia Valverde-Megías · Pilar Cifuentes-Canorea · Jorge Ruiz-Medrano · Pablo Peña-García · Alicia Megías-Fresno · Juan Donate-López · Julian Garcia-Feijoo · Julian Garcia-Feijoo
Efficacy and Time Sensitivity of Amniotic Membrane treatment in Patients with Diabetic Foot Ulcers: A Systematic Review and Meta-analysis Irakoze Laurent · Manirakiza Astère · Kan Ran Wang · Qing-feng Cheng · Qi Fu Li · Qi Fu Li
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain Pedro Mezquita-Raya · Antonio Ramírez de Arellano · Nana Kragh · Gabriela Vega-Hernandez · Johannes Pöhlmann · Wj Valentine · Barnaby Hunt · Barnaby Hunt
Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center Daniela Sofra · Daniela Sofra
Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials Richard E. Gilbert · Christian W. Mende · Ujjwala Vijapurkar · Sue Sha · Michael J. Davies · Mehul Desai · Mehul Desai
Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic Ashu Rastogi · Anil Bhansali · Anil Bhansali
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes Sanjay Kalra · Sanjay Kalra
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey Chaicharn Deerochanawong · Shailendra Bajpai · I. Made Pande Dwipayana · Zanariah Hussein · Maria Aileen Mabunay · Reynaldo Rosales · Shih-Tzer Tsai · Man Wo Tsang · Man Wo Tsang
Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations Xuying Wang · Jiageng Chen · Xiaoqian Liu · Fei Gao · Haozuo Zhao · Duolan Han · Xiyue Jing · Yuanyuan Liu · Zhuang Cui · Changping Li · Jun Ma · Jun Ma
Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis Nicolaas C. Schaper · Annie Nikolajsen · Anna Sandberg · Sarah Buchs · Mette Bøgelund · Mette Bøgelund
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis Uazman Alam · Uazman Alam · David R. Riley · Ravinder S. Jugdey · Shazli Azmi · Satyan Rajbhandari · Kristiaan D’Août · Rayaz A. Malik · Rayaz A. Malik · Rayaz A. Malik
Diabetic Neuropathy and Gait: A Review Milan Kvapil · Martin Prázný · Pavel Holik · Karel Rychna · Barnaby Hunt · Barnaby Hunt
SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review Laure de Decker · Olivier Hanon · Anne-Sophie Boureau · Guillaume Chapelet · Christelle Dibon · Matthieu Pichelin · Gilles Berrut · Bertrand Cariou · Bertrand Cariou
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction Hitoshi Ishii · Yuki Suzaki · Yuko Miyata · Yuko Miyata
Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study Bing Pang · Ying Zhang · Jing Liu · Li-Sha He · Yu-jiao Zheng · Fengmei Lian · Xiaolin Tong · Xiaolin Tong
Correction to: Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis Kathryn Evans Kreider · Katherine Pereira · Blanca Iris Padilla · Blanca Iris Padilla
Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes Irini P. Chatziralli · Panagiotis Theodossiadis · Efstratios Parikakis · Eleni Dimitriou · Tina Xirou · George Theodossiadis · Stamatina Α. Kabanarou · Stamatina Α. Kabanarou
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome Sultan Linjawi · Byung Wan Lee · Ömür Tabak · Susanna Lövdahl · Shanti Werther · Salahedeen Abusnana · Salahedeen Abusnana
Fasting, Diabetes, and Optimizing Health Outcomes for Ramadan Observers: A Literature Review Hadi A. Almansour · Betty Chaar · Bandana Saini · Bandana Saini
Use of 50/50 premixed insulin analogs in Type 2 Diabetes: systematic review and clinical recommendations Christoph Schindler · Andreas L. Birkenfeld · Markolf Hanefeld · Ulrike Schatz · Carsta Köhler · Martin Grüneberg · Diethelm Tschöpe · Matthias Blüher · Christoph Hasslacher · Stefan R. Bornstein · Stefan R. Bornstein
Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol Maja Berković · Ines Bilic-Curcic · Davorka Herman Mahecic · Marina Gradišer · Mladen Grgurevic · Tomislav Bozek · Tomislav Bozek
Long-Term Effectiveness of Liraglutide in Association with Patients Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study Carol Mansfield · Mirko V Sikirica · Amy Pugh · Christine Poulos · Victoria Unmuessig · Raúl Morano · Alan Martin · Alan Martin
Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care Bing Pang · Ying Zhang · Jing Liu · Li-Sha He · Yu-jiao Zheng · Fengmei Lian · Xiaolin Tong · Xiaolin Tong
A Randomized Controlled Trial to Assess the Impact of Proper Insulin Injection Technique Training on Glycemic Control Anthony P. Nunes · Anita M. Loughlin · Qing Qiao · Stephen M. Ezzy · Laura Yochum · C. Robin Clifford · Robert Gately · David D. Dore · John D. Seeger · John D. Seeger
Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK Inna Vladimirovna Misnikova · Valeria Alekseevna Gubkina · Tatyana S. Lakeeva · Alexander Dreval · Alexander Dreval
Detection and Management of Diabetes in England: Results from the Health Survey for England Marc Evans · Sayeed Achha · C. Neslusan · C. Neslusan
Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis Beverley Balkau · Bernard Charbonnel · A. Penfornis · Nora Chraibi · Amir Lahouegue · Céline Faure · Florence Thomas-Delecourt · Bruno Detournay · Bruno Detournay
Prevention of Type 2 Diabetes with the Chinese Herbal Medicine Tianqi Capsule: A Systematic Review and Meta-Analysis Roberto Trevisan · Roberto Trevisan
The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study Mimi Xiao · Ciaran O’Neill · Ciaran O’Neill
Cardiovascular Outcome Studies in Diabetes: How Do We Make Sense of These New Data? W. David Strain · Christine Smith · Christine Smith
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study Ronan Roussel · Bernard Charbonnel · Mourad Behar · J. Gourmelen · Corinne Emery · Bruno Detournay · Bruno Detournay
Timing of Delivery in Gestational Diabetes Mellitus: Need for Person-Centered, Shared Decision-Making Bharti Kalra · Yashdeep Gupta · Sanjay Kalra · Sanjay Kalra
Vitamin D and Diabetic Complications: True or False Prophet? Uazman Alam · Vilashini Arul-Devah · Saad Javed · Rayaz A. Malik · Rayaz A. Malik · Rayaz A. Malik
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment Shira Perl · William Cook · Cheryl Wei · Nayyar Iqbal · Boaz Hirshberg · Boaz Hirshberg
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study Todd A. MacKenzie · Rebecca Zaha · Jeremy M. Smith · Margaret R. Karagas · Nancy E. Morden · Nancy E. Morden
How Much Time Do Families Spend on the Health Care of Children with Diabetes Jane E. Miller · Colleen N. Nugent · Louise B. Russell · Louise B. Russell
Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin Lawrence A. Leiter · Gisle Langslet · Ujjwala Vijapurkar · Michael J. Davies · William Canovatchel · William Canovatchel
Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study Ayman A. Al Hayek · Asirvatham Alwin Robert · Rim Braham · Mohamed Abdulaziz Al Dawish · Mohamed Abdulaziz Al Dawish
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes Kyle T. Baron · Sreeraj Macha · Uli C. Broedl · Valerie Nock · Silke Retlich · Matthew M. Riggs · Matthew M. Riggs
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis Bo Ahrén · Gagik Galstyan · Jean Francois Gautier · Francesco Giorgino · Fernando Gomez-Peralta · Michael Krebs · Elena Nikonova · William Stager · Hernando Vargas-Uricoechea · Hernando Vargas-Uricoechea
Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey Meryl Brod · Gagik Galstyan · Ambika Gopalakrishnan Unnikrishnan · Ilana Harman-Boehm · Vinay Prusty · Fernando Lavalle · Margaret McGill · Angela Murphy · Félix Puchulu · Félix Puchulu
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers William Green · Matthew Taylor · Matthew Taylor
The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs Sanjay Kalra · Yashdeep Gupta · Yashdeep Gupta
Not All Diabetes in Infants is Type 1: A Case Report Karla M. Arce · Kevin M. Pantalone · Kevin M. Pantalone
Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes Lisa Elliott · Carrie Fidler · Andrea Ditchfield · Trine Stissing · Trine Stissing
Peer-to-Peer, Interactive GP Education can Reduce Barriers to Best Practice in Diabetes Management Gary Deed · Gary Kilov · Patrick Phillips · Anita Sharma · Stephen Leow · Ian Arthur · John Barlow · Mark Kennedy · Mark Kennedy
A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus Sheena Kayaniyil · Greta Lozano-Ortega · Heather A. Bennett · Kristina Johnsson · Alka Shaunik · Susan Grandy · Bernt Kartman · Bernt Kartman
The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries Meryl Brod · Annie Nikolajsen · James Weatherall · Kathryn M. Pfeiffer · Kathryn M. Pfeiffer
Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials Christian W. Mende · Arie Katz · Arie Katz
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials Markolf Hanefeld · Louis Monnier · Oliver Schnell · David Raymond Owens · David Raymond Owens
Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment Thomas Blevins · James Ruggles · Elise Hardy · Elise Hardy
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Sandro Gentile · Felice Strollo · Antonio Ceriello · Antonio Ceriello
Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus Tomoyuki Katsuno · Hiroki Ikeda · Mitsuyoshi Namba · Mitsuyoshi Namba
Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence Saud Al Sifri · Kashif Rizvi · Kashif Rizvi
Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data Dalit Goldstein · Gabriel Chodick · Varda Shalev · Brian Larsen Thorsted · Lisa Elliott · Avraham Karasik · Avraham Karasik
Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis Lays P. Marra · Vania E. Araújo · Thales B. C. Silva · Leonardo Maurício Diniz · Augusto Afonso Guerra Júnior · Francisco de Assis Acurcio · Brian Godman · Brian Godman · Brian Godman · Juliana Álvares · Juliana Álvares
Faulty Injection Technique: A Preventable But Often Overlooked Factor in Insulin Allergy Partha Pratim Chakraborty · Sugata Narayan Biswas · Shinjan Patra · Shinjan Patra
Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis Yshai Yavin · Traci A. Mansfield · Agata Ptaszynska · Kristina Johnsson · Shamik Parikh · Eva Johnsson · Eva Johnsson
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review Amrita Ostawal · Emina Mocevic · Nana Kragh · Weiwei Xu · Weiwei Xu
Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes Rong Qiu · Dainius Balis · George Capuano · John Xie · Gary Meininger · Gary Meininger
Practical Approaches to Diabetes Care: An Introduction Marc Evans · Abigail Maisey · Abigail Maisey
A Practical Approach to Gastrointestinal Complications of Diabetes Abigail Maisey · Abigail Maisey
Letter to the Editor Regarding: Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes John S. Baird · John S. Baird
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures Valentina Scattolini · Camilla Luni · Camilla Luni · Alessandro Zambon · Silvia Galvanin · Onelia Gagliano · Catalin Dacian Ciubotaru · Angelo Avogaro · Fabio Mammano · Nicola Elvassore · Gian Paolo Fadini · Gian Paolo Fadini
Medication Adherence Contributes to an Improved Quality of Life in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study Sofa D. Alfian · Hadyana Sukandar · Keri Lestari · Rizky Abdulah · Rizky Abdulah
Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin Kate Van Brunt · Bradley Curtis · Tibor Ivanyi · Elemer Balogh · Corina Chalkiadaki · Sharon MacLachlan · David Neasham · Mireia Raluy-Callado · Mireia Raluy-Callado
Lixisenatide Improves Glycemic Control in Asian Type 2 Diabetic Patients Inadequately Controlled With Oral Antidiabetic Drugs: An Individual Patient Data Meta-Analysis Hua Shu · Li-na Gu · Li-chuang Men · Ju-ming Lu · Ju-ming Lu
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus Jason Gordon · Jason Gordon · Phil McEwan · Michael Hurst · Jorge Puelles · Jorge Puelles
Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Hao Liu · Yun Hu · Feng-fei Li · Bing-li Liu · Xiao-fei Su · Jian-hua Ma · Jian-hua Ma
Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease Joel Zonszein · Per-Henrik Groop · Per-Henrik Groop
Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis Thomas Wilke · Sabrina Mueller · Antje Groth · Bjoern Berg · Andreas Fuchs · Mirko V Sikirica · John Logie · Alan Martin · Ulf Maywald · Ulf Maywald
Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes Bhavana Sosale · Aravind Sosale · Arpandev Bhattacharyya · Arpandev Bhattacharyya
A Practical Approach to Glucose Abnormalities in Cystic Fibrosis Gregory C. Jones · Christopher A. R. Sainsbury · Christopher A. R. Sainsbury
Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care Brian Lee · Dace L. Trence · Silvio E. Inzucchi · Jay Lin · Steven Haimowitz · Elizabeth Wilkerson · Cara Williams · Marc Mosier · Terry Dex · Terry Dex
Cross-National Variation in Glycemic Control and Diabetes-Related Distress Among East Asian Patients Using Insulin: Results from the MOSAIc Study Ikuro Matsuba · Tasuku Sawa · Takehiro Kawata · Akira Kanamori · Dingfeng Jiang · Hideo Machimura · Hiroshi Takeda · Jeong Hee Han · Ke Wang · Keiji Tanaka · Li Shen · Miho Ajima · Mizuki Kaneshiro · Sang-Wook Kim · Shinichi Umezawa · Taro Asakura · Shuichi Suzuki · Seoyoung C. Kim · Seoyoung C. Kim · Seoyoung C. Kim
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records Wlodzimierz M. Kolaczynski · M. Hankins · S.H. Ong · Hartmut Richter · Andreas Clemens · Massoud Toussi · Massoud Toussi
Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA Meryl Brod · Annie Nikolajsen · James Weatherall · Kathryn M. Pfeiffer · Kathryn M. Pfeiffer
Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden Marcus Lind · Per-Olov Matsson · Ragnar Linder · Irene Svenningsson · Leif Jorgensen · U.J. Ploug · H. Gydesen · Mozhgan Dorkhan · Sara Larsen · Gunnar Johansson · Gunnar Johansson
Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens Michelle Downie · Gary Kilov · Jencia Wong · Jencia Wong · Jencia Wong
Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials Han Chen · Xiaoying Zhou · Tao Chen · Bingtuan Liu · Wujuan Jin · Huiyuan Gu · Tianyuan Hong · Guoxin Zhang · Guoxin Zhang
Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years Nandu Thalange · Abdullah Bereket · Lisbeth Bjerring Jensen · Line Conradsen Hiort · Valentina Peterkova · Valentina Peterkova
Glycated Hemoglobin, Body Weight and Blood Pressure in Type 2 Diabetes Patients Initiating Dapagliflozin Treatment in Primary Care: A Retrospective Study John Wilding · Clifford J. Bailey · U. Rigney · Betina Blak · Wendy Beekman · Cathy Emmas · Cathy Emmas
Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes Gregory C. Jones · Zhou M. Chong · Jennifer Gilmour · Christine Matheson · Gordon MacGregor · Christopher A. R. Sainsbury · Christopher A. R. Sainsbury
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective Marc Evans · Jens Gundgaard · Brian Bekker Hansen · Brian Bekker Hansen
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study Mohamed Khattab · Khalifa Mahmoud · Inass Shaltout · Inass Shaltout
Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial Sanjay Kalra · Sanjay Kalra
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study Vincent Lak · Ann-Marie Svensson · Mervete Miftaraj · Stefan Franzén · Björn Eliasson · Björn Eliasson
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus Margaret Bannister · Jenny Berlanga · Jenny Berlanga
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment Merlin C. Thomas · Päivi M. Paldánius · Rajeev Ayyagari · S.H. Ong · Per-Henrik Groop · Per-Henrik Groop · Per-Henrik Groop
Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization Leslie Montejano · Lien Vo · Donna McMorrow · Donna McMorrow

Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study
Diabetes Therapy | 2018
Paul H. Lee · Yunjuan Gu · Man Yi Yeung · Carol H.Y. Fong · Yu-Cho Woo · Ws Chow · Kathryn C.B. Tan · Karen Siu Ling Lam · Karen Siu Ling Lam
Individuals with Type 1 and Type 2 Diabetes Mellitus Trade Increased Hyperglycemia for Decreased Hypoglycemia When Glycemic Variability is not Improved
Diabetes Therapy | 2018
Leonardo Spatola · Silvia Finazzi · Claudio Angelini · Marco Dauriz · Salvatore Badalamenti · Salvatore Badalamenti